← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2002Last known activity
Sep 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT06488482CollaboratorPhase 3Sep 30, 2024
- NCT06419946CollaboratorPhase 3May 15, 2024
- NCT04824599Reponsible party - principal investigatorN/AFeb 19, 2021
- NCT04824599Lead sponsorN/AFeb 19, 2021
- NCT04426123Study directorPhase 2Jul 1, 2020
- NCT02918110CollaboratorPhase 4Sep 1, 2016
- NCT00405158Lead sponsorN/AJan 1, 2002
- NCT00405158Study directorN/AJan 1, 2002
- NCT00405158Overall official - principal investigatorN/AJan 1, 2002
Details
- Last known activity
- Sep 30, 2024